Cluster of Excellence of the German Research Foundation (DFG)
Sunglasses will always be crucial for the protection of our eyes from UV radiation, even when the protective...
Ultrashort light pulses take centre stage of the MAP research at the campus in Garching. Physicists and medical...
Scientists at MAP have managed to significantly improve the phase-contrast x-ray method by analyzing so-called “speckles”- specific patterns that arise when radiation hits rough surfaces. Reports about this new method are featured in the online science magazines Pro Physik and Medizin Aspekte.
An article on medicalphysicsweb on the research of Prof. Katia Parodi and colleagues on "Ionoacoustics: a new take on range verification" which she recently presented at the ICTR-PHE meeting in Geneva, Switzerland
Prof. Stephanie Combs has taken over a tremendous responsibility. Since April 2014, she has been in charge of TU Munich’s clinic for radiation oncology and radiotherapy, which forms part of the “Klinikum rechts der Isar”, following in the footsteps of Prof. Michael Molls.
However, 37-year-old Combs is used to challenges: one of her areas of expertise is the treatment of complex and fast-growing tumours. She has obtained outstanding results treating, for instance, aggressive and malignant brain tumours called glioma. Her strategy, a combination of heavy-ion-radiotherapy and chemotherapy, has earned her international esteem.
One of Combs’ favorite aspects of her specialty is the fact that it combines biology, technology and medical science: “That was the reason I chose radiation oncology”, she says. While studying medicine in Heidelberg, Combs spent some time in the US, studying and researching in San Antonio and Norfolk, before earning her doctorate with a specialization in neuroanatomy in 2003. Six years later, she completed her training as a specialist in the field of radiotherapy and underwent the process for qualifying as a professor in Germany. Before coming to Munich, the passionate researcher worked as a senior physician at the university clinic Heidelberg, where she also conducted research together with MAP-members Katia Parodi and Jan Wilkens.
Her research within the MAP-cluster will focus on medical imaging, technological advancements in radiotherapy, as well as the combination of heavy-ion-radiotherapy and chemotherapy. However, despite her field being quite technical, Combs is always careful to keep the well-being of her patients in mind. “The focus must always be on them.”, she says. In addition to actual tumour treatment, she therefore encourages complementary therapies, such as diet- or exercise-related programs. “It is a known fact that lifestyle choices and quality of life have a massive impact when it comes to therapeutic success in oncology.”
She hopes to intensify her collaborations with scientists from other disciplines, for which the MAP research community provides ideal conditions: “The cooperation of physics and medical science holds lots of possibilities to advance radiotherapy.” She points out that technical innovations and scientific findings should be quickly transferred into clinical practice – one of many examples of Stephanie Combs’ focus on her patients.
Stephanie Combs is also featured in our current Newsletter.